Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Polyphyllin I
Cat. No.:
OB0225LY-0491
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Polyphyllin I has anti-angiogenic effects and anti-cancer properties.
Synonym:
50773-41-6; (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-5-[(2S,3R,4R,5S)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4-hydroxy-6-(hydroxymethyl)-2-[(1S,2S,4S,5'R,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol
CAS No.:
50773-41-6
Compound CID:
11018329
Formula:
C44H70O16
Formula Weight:
855.02
Specification
Relative Density:
1.4 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Polyphyllin I can be used for apoptosis and cell cycle studies.
Library Information
Targets:
Serine/Threonine kinases; PIKKs
Receptors:
Akt; JNK; mTOR; PDK1
Pathways:
Apoptosis; Cytoskeletal signaling; Autophagy; MAPK; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-7
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 64.33 mM
